These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 10825001)

  • 21. Suggestive linkage of familial primary cutaneous amyloidosis to a locus on chromosome 1q23.
    Lin MW; Lee DD; Lin CH; Huang CY; Wong CK; Chang YT; Liu HN; Hsiao KJ; Tsai SF
    Br J Dermatol; 2005 Jan; 152(1):29-36. PubMed ID: 15656797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytogenetic, spectral karyotyping, fluorescence in situ hybridization, and comparative genomic hybridization characterization of two new secondary leukemia cell lines with 5q deletions, and MYC and MLL amplification.
    Knutsen T; Pack S; Petropavlovskaja M; Padilla-Nash H; Knight C; Mickley LA; Ried T; Elwood PC; Roberts SJ
    Genes Chromosomes Cancer; 2003 Jul; 37(3):270-81. PubMed ID: 12759925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of the chromosomal region 5q11-q31 in the myeloid cell line HL-60: characterization by comparative genomic hybridization and fluorescence in situ hybridization.
    Shipley J; Weber-Hall S; Birdsall S
    Genes Chromosomes Cancer; 1996 Mar; 15(3):182-6. PubMed ID: 8721684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Constitutional t(5;7)(q11;p15) rearranged to acquire monosomy 7q and trisomy 1q in a patient with myelodysplastic syndrome transforming to acute myelocytic leukemia.
    Ganly P; McDonald M; Spearing R; Morris CM
    Cancer Genet Cytogenet; 2004 Mar; 149(2):125-30. PubMed ID: 15036888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneity of structural abnormalities in the 7q31.3 approximately q34 region in myeloid malignancies.
    González MB; Gutiérrez NC; García JL; Schoenmakers EF; Solé F; Calasanz MJ; San Miguel JF; Hernández JM
    Cancer Genet Cytogenet; 2004 Apr; 150(2):136-43. PubMed ID: 15066321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel pheochromocytoma susceptibility loci identified by integrative genomics.
    Dahia PL; Hao K; Rogus J; Colin C; Pujana MA; Ross K; Magoffin D; Aronin N; Cascon A; Hayashida CY; Li C; Toledo SP; Stiles CD;
    Cancer Res; 2005 Nov; 65(21):9651-8. PubMed ID: 16266984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strong indication for a breast cancer susceptibility gene on chromosome 8p12-p22: linkage analysis in German breast cancer families.
    Seitz S; Rohde K; Bender E; Nothnagel A; Kölble K; Schlag PM; Scherneck S
    Oncogene; 1997 Feb; 14(6):741-3. PubMed ID: 9038382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conventional and molecular cytogenetic findings of myelodysplastic syndrome patients.
    Yilmaz Z; Sahin FI; Kizilkilic E; Karakus S; Boga C; Ozdogu H
    Clin Exp Med; 2005 Jul; 5(2):55-9. PubMed ID: 16096854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis.
    Christiansen DH; Andersen MK; Pedersen-Bjergaard J
    J Clin Oncol; 2001 Mar; 19(5):1405-13. PubMed ID: 11230485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of RUNX1/AML1 as a classical tumor suppressor gene.
    Silva FP; Morolli B; Storlazzi CT; Anelli L; Wessels H; Bezrookove V; Kluin-Nelemans HC; Giphart-Gassler M
    Oncogene; 2003 Jan; 22(4):538-47. PubMed ID: 12555067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions.
    Douet-Guilbert N; Basinko A; Morel F; Le Bris MJ; Ugo V; Morice P; Berthou C; De Braekeleer M
    Ann Hematol; 2008 Jul; 87(7):537-44. PubMed ID: 18350294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FISH investigation of 5q and 7q deletions in MDS/AML reveals hidden translocations, insertions and fragmentations of the same chromosomes.
    Lessard M; Herry A; Berthou C; Léglise MC; Abgrall JF; Morice P; Flandrin G
    Leuk Res; 1998 Apr; 22(4):303-12. PubMed ID: 9669835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical relevance of cytogenetics in myelodysplastic syndromes.
    Bernasconi P; Boni M; Cavigliano PM; Calatroni S; Giardini I; Rocca B; Zappatore R; Dambruoso I; Caresana M
    Ann N Y Acad Sci; 2006 Nov; 1089():395-410. PubMed ID: 17261783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequent loss of heterozygosity without loss of genetic material in acute myeloid leukemia with a normal karyotype.
    Gorletta TA; Gasparini P; D'Elios MM; Trubia M; Pelicci PG; Di Fiore PP
    Genes Chromosomes Cancer; 2005 Nov; 44(3):334-7. PubMed ID: 16015648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of balanced rearrangements of chromosome 6 in acute leukemia: clustered breakpoints in q22-q23 and possible involvement of c-MYB in a new recurrent translocation, t(6;7)(q23;q32 through 36).
    Sinclair P; Harrison CJ; Jarosová M; Foroni L
    Haematologica; 2005 May; 90(5):602-11. PubMed ID: 15921375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anatomy of the 5q- deletion: different sex ratios and deleted 5q bands in MDS and AML.
    Pedersen B
    Leukemia; 1996 Dec; 10(12):1883-90. PubMed ID: 8946926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes.
    MacKinnon RN; Kannourakis G; Wall M; Campbell LJ
    Cancer Genet; 2011 Apr; 204(4):187-94. PubMed ID: 21536236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Detection of common chromosome abnormalities in myelodysplastic syndrome with a panel fluorescence in situ hybridization].
    Shen Y; Xue Y; Li J; Pan J; Wu Y; Chen S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):160-3. PubMed ID: 12673589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delineation of the minimal commonly deleted segment and identification of candidate tumor-suppressor genes in del(9q) acute myeloid leukemia.
    Sweetser DA; Peniket AJ; Haaland C; Blomberg AA; Zhang Y; Zaidi ST; Dayyani F; Zhao Z; Heerema NA; Boultwood J; Dewald GW; Paietta E; Slovak ML; Willman CL; Wainscoat JS; Bernstein ID; Daly SB
    Genes Chromosomes Cancer; 2005 Nov; 44(3):279-91. PubMed ID: 16015647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Deletion of the long arm of chromosome 5 in patients with hematologic malignancies].
    Brezinová J; Zemanová Z; Michalová K
    Cas Lek Cesk; 2001 Feb; 140(2):43-6. PubMed ID: 11262906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.